Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
Metabolic rewiring is considered as a primary feature of cancer. Malignant cells reprogram metabolism pathway in response to various intrinsic and extrinsic drawback to fuel cell survival and growth. Among the complex metabolic pathways, pyrimidine biosynthesis is conserved in all living organism an...
Main Authors: | Wanyan Wang, Jiayan Cui, Hui Ma, Weiqiang Lu, Jin Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.684961/full |
Similar Items
-
DHODH and cancer: promising prospects to be explored
by: Yue Zhou, et al.
Published: (2021-05-01) -
A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode
by: Ting Zeng, et al.
Published: (2019-08-01) -
Pyrimidine Metabolism in Rhizobium: Physiological Aspects of Pyrimidine Salvage
by: Ibrahim, Mohamed M.
Published: (1989) -
Pyrimidine Metabolism in Streptomyces griseus
by: Hughes, Lee E. (Lee Everette)
Published: (1994) -
Impaired virulence factor production in a dihydroorotate dehydrogenase mutant (pyrD) of Pseudomonas aeruginosa.
by: Ralli, Pooja
Published: (2005)